One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling

BACKGROUND: Initial serological testing for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is conducted using either rapid diagnostic tests (RDT) or laboratory-based enzyme immunoassays (EIA)s for detection of hepatitis B surface antigen (HBsAg) or antibodies to HCV (anti-HCV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, John V., Easterbrook, Philippa, Sands, Anita R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688456/
https://www.ncbi.nlm.nih.gov/pubmed/29143611
http://dx.doi.org/10.1186/s12879-017-2774-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688456/
https://www.ncbi.nlm.nih.gov/pubmed/29143611
http://dx.doi.org/10.1186/s12879-017-2774-1

Ejemplares similares